A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

This study has been completed.

Sponsor:

Information provided by:

Otsuka Pharmaceutical Co., Ltd.

ClinicalTrials.gov Identifier:

NCT00606177

First received: January 19, 2008

Last updated: July 10, 2011

Last verified: July 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2010
Primary Completion Date:	November 2010 (Final data collection date for primary outcome measure)